[Bleomycin emulsion for intralesional instillation in advanced oropharyngeal carcinomas. A case report on local bleomycin application].
Local therapy of head and neck cancer using a special bleomycin emulsion as an intratumoral applicarted cytotoxic agent is not established in regular antitumor therapy. It's use only is supposed to be regarded as an "ultima ratio" possibility when other usual methods like surgery, radiotherapy or systemic cytostatic therapy have failed. The procedure of intralesional bleomycin emulsion application will be described and the advantages and disadvantages will be discussed by means of a long-term case report.
Merten
H A
HA
Kieferchirurgische Abteilung, Universitätsklinik Göttingen.
Hönig
J F
JF
D000328:Adult; D001761:Bleomycin / Q000008:administration & dosage*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002626:Chemistry, Pharmaceutical; D004339:Drug Compounding; D004655:Emulsions; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D009959:Oropharyngeal Neoplasms / Q000188:drug therapy*; D012074:Remission Induction
D004655:Emulsions; D001761:Bleomycin
Bleomycin-Emulsion zur intraläsionalen Instillation bei fortgeschrittenen Oropharynx-Karzinomen. Kasuistik zur lokalen Bleomycin-Applikation.